Approaches to improve angiogenesis in tissue-engineered skin

Wound Repair and Regeneration

Volumn 12, Issue 6, 2004, Pages 635-642

  Sahota, Parbinder S ^a   Burn, J Lance ^b   Brown, Nicola J ^b   MacNeil, Sheila ^a,c  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c Sir Robert Hadfield Building ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DERMIS; ENDOTHELIUM CELL; EPIDERMIS; FIBROBLAST; HUMAN; HUMAN CELL; HYPOXIA; KERATINOCYTE; MICROVASCULATURE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SCORING SYSTEM; SKIN; TISSUE ENGINEERING; VASCULARIZATION;

CELL CULTURE TECHNIQUES; DERMIS; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; KERATINOCYTES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN; SKIN TRANSPLANTATION; STATISTICS, NONPARAMETRIC; TISSUE ENGINEERING;

EID: 9644289212     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1067-1927.2004.12608.x     Document Type: Article

References (19)

1. Ghosh MM, Boyce SG, Layton C, Freedlander E, MacNeil S. A comparison of methodologies for the preparation of human epidermal-dermal composites. Ann Plast Surg 1997;39:390-404.
2. Ralston DR, Layton C, Dailey AJ, Boyce SG, Freedlander E, MacNeil S. Keratinocytes contract human dermal extracellular matrix and reduce soluble fibronectin production by fibroblasts in a skin composite model. Br J Plast Surg 1997;50:1-7.
3. Chakrabarty KH, Dawson RA, Harris P, Layton C, Babu M, Gould L, Phillips J, Leigh I, Green C, Freedlander E, MacNeil S. Development of autologous human dermal-epidermal composites based on sterilized human allodermis for clinical use. Br J Dermatol 1999;141:811-23.
4. Sahota PS, Burn JL, Heaton M, Freedlander E, Suvarna SK, Brown NJ, MacNeil S. Development of a reconstructed human skin model for angiogenesis. Wound Rep Reg 2003;11:275-84.
5. Palao R, Gomez P, Huguet P. Burned breast reconstructive surgery with Integra dermal regeneration template. Br J Plast Surg 2003 April;56:252-9.
6. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinising colonies from single cells. Cell 1975;6:331-44.
7. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992;99:683-90.
8. Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995;105:44-50.
9. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor regulation through alpha1beta1 and alpha2beta1 integrins. Proc Nat Acad Sci USA 1997;94:13612-7.
10. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-8.
11. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 1997;108:263-8.
12. Trompezinski S, Denis A, Vinche A, Schmitt D, Viac J. IL-4 and interferon-gamma differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts. Exp Dermatol 2002;11:224-31.
13. Brenneisen P, Blaudschun R, Gille J, Schneider L, Hinrichs R, Wlaschek M, Eming S, Scharffetter-Kochanek K. Essential role of an activator protein-2 (AP-2) /specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. Biochem J 2003;369:341-9.
14. Black AF, Berthod F, L'heureux N, Germain L, Auger FA. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J 1998;12:1331-40.
15. Meininger CJ, Schelling ME, Granger HJ. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 1988;255 (3 Part 2):H554-62.
16. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 1995;92:11-4.
17. Willam C, Koehne P, Jurgensen JS, Grafe M, Wagner KD, Bachmann S, Frei U, Eckardt KU. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ Res 2000;87:370-7.
18. Das A, McGuire PG. Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Prog Retin Eye Res 2003;22:721-48.
19. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, Campochiaro PA, Semenza GL. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003;93:1074-81.